In addition, combined with tamoxifen, thymoquinone led to a substantial increased apoptosis and marked inhibition of cell growth in breast cancer, which resulted in regulation of multiple cell signaling targets including inactivation of Akt and degradation of XIAP, an endogenous inhibitor of apoptosis by inactivating key caspases [105]. The gene discussed is AKT1; the disease is breast carcinoma.